The FDA granted orphan designation to Sanofi US Services’ rilzabrutinib as a treatment of autoimmune hemolytic anemia, according to a post to the agency’s website. Discover th ...
Patients treated with on dupilumab showed significant improvement in sustained BP remission compared with those on placebo.
New therapeutic 'cocktails' may provide long-lasting relief for treatment-resistant asthma and other immune system inflammatory diseases.
Repurposing amlodipine, a commonly used blood pressure medicine, could help manage attention-deficit/ hyperactivity disorder (ADHD) symptoms, according to an international study involving the ...
Millions of Brits live with asthma and rely on a variety of treatments to manage their condition, but a new study has raised ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results